Camber Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-300,000
Closed -$6.55M 40
2023
Q3
$6.55M Sell
300,000
-1,250,000
-81% -$26.1M 0.22% 38
2023
Q2
$29.6M Hold
1,550,000
0.96% 25
2023
Q1
$30.1M Buy
1,550,000
+200,000
+15% +$3.48M 0.93% 21
2022
Q4
$21.7M Hold
1,350,000
0.74% 27
2022
Q3
$21.2M Sell
1,350,000
-300,000
-18% -$5.8M 0.65% 34
2022
Q2
$34.4M Buy
1,650,000
+1,350,000
+450% +$27.8M 1.49% 20
2022
Q1
$6.8M Buy
+300,000
New +$5.86M 0.25% 34

Other funds holding EXEL

Camber Capital Management's EXEL Position: Q4 2023 in Review

Camber Capital Management sold out of Exelixis (EXEL) in Q4 2023, closing a stake of 300,000 shares — an estimated $6.55M sold.

Camber Capital Management first reported a position in EXEL in Q1 2022 and held it in 7 quarters. The position peaked at $34.4M in Q2 2022. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

  • Camber Capital Management reported no remaining Exelixis position as of Q4 2023 after selling out during the quarter.
  • Camber Capital Management sold 300,000 Exelixis shares in Q4 2023, an estimated $6.55M.
  • Camber Capital Management first reported a position in Exelixis in Q1 2022 and held it in 7 quarters.
  • Camber Capital Management's Exelixis position peaked at $34.4M in Q2 2022.
  • 425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on Camber Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.